TCRT
Alaunos Therapeutics, Inc. - Common Stock (TCRT)
$63
About Alaunos Therapeutics, Inc. - Common Stock (TCRT)
Alaunos Therapeutics, Inc. is a biopharmaceutical company and clinical-stage oncology-focused cell therapy company, which engages in the development of adoptive TCR engineered T-cell therapies, or TCR-T, designed to treat multiple solid tumor types in large cancer patient populations with unmet clinical needs. Its pipeline includes Library TCR-T cell and mblL-15 TCR-T cell Therapy. The company was founded in 2003 and is headquartered in Fort Lauderdale, FL.
Details
Daily high
$2.70
Daily low
$2.39
Price at open
$2.39
52 Week High
$6.20
52 Week Low
$1.31
Market cap
5.9M
Dividend yield
0.00%
Volume
21,247
Avg. volume
20,013
P/E ratio
-1.14
Alaunos Therapeutics, Inc. - Common Stock News
Details
Daily high
$2.70
Daily low
$2.39
Price at open
$2.39
52 Week High
$6.20
52 Week Low
$1.31
Market cap
5.9M
Dividend yield
0.00%
Volume
21,247
Avg. volume
20,013
P/E ratio
-1.14